Long-term efficacy of tafamidis in patients with transthyretin amyloid cardiomyopathy by National Amyloidosis Centre stage

Damy, T., Wang, R., Maurer, M. S., Gillmore, J. D., & Fontana, M. (2025). Long‐term efficacy of tafamidis in patients with transthyretin amyloid cardiomyopathy by National Amyloidosis Centre stage. European Journal of Heart Failure. Portico. https://doi.org/10.1002/ejhf.3696
Authors:
Thibaud Damy
Rong Wang
Mathew S Maurer
Julian D Gillmore
Marianna Fontana
Affiliated Authors:
Mathew S Maurer
Columbia Affiliation:
Subjects:
Molecular Mechanisms of Amyloidosis (OpenAlex Topic)
Hypereosinophilic Syndrome and Related Disorders (OpenAlex Topic)
Epidemiology and Pathogenesis of Pneumocystis Pneumonia (OpenAlex Topic)
Author Keywords:
attr‐cm staging
amyloidosis
cardiomyopathy
transthyretin
elink
Publication Type:
Article
Unique ID:
10.1002/ejhf.3696
PMID:
40488446
DOI:
10.1002/ejhf.3696
Journal:
European Journal of Heart Failure
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record

Record Created: